课题基金 / 基金详情

Modulation of T cell activation by the Beta2-Adrenergic Receptor

Modulation of T cell activation by the Beta2-Adrenergic Receptor
Beta2 肾上腺素受体对 T 细胞活化的调节
批准号:
418522-2013
负责人:
Darlington, Peter
金额:
$2.33万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-01-01 至 2018-12-31

项目摘要

项目成果

Darlington, Peter的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
BACKGROUND: Adaptive immune responses are coordinated by T lymphocytes, a white blood cell that circulates through blood and lymphatics of most vertebrate animals. One area that has not been widely explored is the effects of stress-activated hormones such as catecholamines, for example noradrenaline and adrenaline. T lymphocytes can sense catecholamines through a receptor called the beta2-adrenergic receptor, but how this alters adaptive immune responses is not very well understood. HYPOTHESIS AND RATIONALE: The hypothesis is that the catecholamines can either inhibit or activate T lymphocytes, depending on the types of signals from the beta2-adrenergic receptor. The first objective of this research program is to study in detail how the beta2-adrenergic receptor sends signals to T lymphocytes. The second objective of the program is to determine how catecholamines affect the ability of T lymphocytes to function in terms of their expansion and effector functions that are relevant to immunity. SIGNIFICANCE: Adaptive immune responses are necessary to fight infections, but can also cause autoimmunity, a condition where a person's own organs are attacked by the immune system. Autoimmune conditions affect millions of Canadians especially women. The link with catecholamines suggests that stress (chronic and otherwise) would affect adaptive immunity. The anticipated results we will achieve will increase our basic understanding of the immune system, and help scientists and doctors better treat infections and autoimmunity. The work also applies to maintaining healthy immunity in livestock and fish.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
  • 批准号:
    RGPIN-2019-06980
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.33万
  • 财政年份:
    2022
  • 负责人:
    Darlington, Peter
  • 依托单位:
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
  • 批准号:
    RGPIN-2019-06980
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.33万
  • 财政年份:
    2021
  • 负责人:
    Darlington, Peter
  • 依托单位:
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
  • 批准号:
    RGPIN-2019-06980
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.33万
  • 财政年份:
    2020
  • 负责人:
    Darlington, Peter
  • 依托单位:
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
  • 批准号:
    RGPIN-2019-06980
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.33万
  • 财政年份:
    2019
  • 负责人:
    Darlington, Peter
  • 依托单位:
国内基金
海外基金
全细胞疫苗Cell@MnO2的乳腺癌术后免疫响应监测与放射免疫治疗研究
  • 批准号:
    QN25H220002
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    顾媛
  • 依托单位:
染色体外环状DNA以cell-in-cell途径促进基因横向传递和扩增的研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    15.0万元
  • 批准年份:
    2024
  • 负责人:
    王锐智
  • 依托单位:
GMFG/F-actin/cell adhesion 轴驱动 EHT 在造 血干细胞生成中的作用及机制研究
  • 批准号:
    TGY24H080011
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    李鸿鹄
  • 依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    赵福军
  • 依托单位: